9306 completed, 2261 recruiting, 1934 unknown, 1249 terminated. 3736 Phase 2, 3682 Not applicable, 2430 Phase 1, 2133 Phase 3, 805 Phase 4.
Follow Genetic Diseases, Inborn: new trials by email Literature Review of Genetic Diseases, Inborn trials Research Report on Genetic Diseases, Inborn
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients Skin Cleanser Combination No.1 - Atopic Dermatitis | Phase 4 | Not yet recruiting | Boston Children's Hospital | 100 | 2031-01-01 | 2026-03-10 |
| Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis Ivermectin Pill - Atopic Dermatitis | Phase 2 | Withdrawn | Stanford University | 2030-12-01 | 2024-12-02 | |
| Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease KL003 Cell Injection - Sickle Cell Disease | Not applicable | Suspended | Institute of Hematology & Blood Diseases Hospital, China | 3 | 2028-03-01 | 2026-11-05 |
| Prenatal Transplantation for Fetuses With Fanconi Anemia IUHSCT for FA-affected fetuses - Fanconi Anemia, Anemia, Hypoplastic, Congenital | Phase 1 / Phase 2 | Not yet recruiting | Agnieszka Czechowicz | 12 | 2028-01-01 | 2026-06-16 |
| To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria GS1168 injection - Phenylketonuria (PKU) | Early Phase 1 | Not yet recruiting | Gritgen Therapeutics Co., Ltd. | 9 | 2027-12-31 | 2026-09-10 |
| Self-administered Acupressure in Patients With Sickle Cell Disease Verum Acupressure (using AcuWand), Sham Acupressure (using AcuWand) - Sickle Cell Disease (SCD) | Not applicable | Not yet recruiting | University of Cincinnati | 300 | 2027-10-01 | 2026-10-15 |
| Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease Individuation and Perspective-Taking (IPT), pediatric SCD pain management education session - Sickle Cell Disease, Sickle Cell Anemia in Children | Not applicable | Not yet recruiting | Connecticut Children's Medical Center | 30 | 2027-09-01 | 2026-04-29 |
| Evaluation of Efficacy and Safety of a Single Dose of Exa-cel in Participants With Severe Sickle Cell Disease, βS/ βC Genotype Exa-cel - Sickle Cell Disease | Phase 3 | Withdrawn | Vertex Pharmaceuticals Incorporated | 2027-07-31 | 2026-03-25 | |
| Epidermal Growth Factor Receptor Inhibition for Keratinopathies Erlotinib - Epidermolytic Ichthyosis, Palmoplantar Keratoderma | Phase 1 / Phase 2 | Not yet recruiting | Northwestern University | 44 | 2027-07-01 | 2026-08-03 |
| Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease MHB018A injection - Thyroid Eye Disease (TED) | Phase 3 | Not yet recruiting | Minghui Pharmaceutical (Hangzhou) Ltd | 219 | 2027-07-01 | 2026-06-04 |
| Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome NTI164, Placebo - RETT Syndrome With Proven MECP2 Mutation, Rett Syndrome | Phase 2 / Phase 3 | Not yet recruiting | Fenix Innovation Group | 40 | 2027-07-01 | 2026-09-09 |
| Lentiviral Gene Therapy for CGD Infusion of lentiviral TYF-CGD-modified autologous stem cells - Chronic Granulomatous Disease | Not applicable | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 10 | 2027-07-01 | 2026-11-02 |
| JULÄINE™ - Neck Skin Laxity Clinical Investigation Poly-L-Lactic Acid - Neck Skin Laxity | Not applicable | Not yet recruiting | Nordberg Medical AB | 68 | 2027-07-01 | 2026-11-16 |
| SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection Direct intravenous injection of ivlv-X1 lentiviral vector - SCID, X-Linked | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 10 | 2027-06-30 | 2026-11-03 |
| Lentiviral FIX Gene Therapy YUVA-GT-F901 - Hemophilia B | Phase 1 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 10 | 2027-06-01 | 2026-11-02 |
| IT and IV Lentiviral Gene Therapy for X-ALD Intrathecal and intravenous LV gene therapy - X-linked Adrenoleukodystrophy | Not applicable | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 30 | 2027-06-01 | 2026-11-02 |
| Lentiviral Hematopoietic Stem Cell Gene Therapy for MLD Lentiviral TYF-ARSA correction of patient's autologous HSCs - Metachromatic Leukodystrophy (MLD) | Not applicable | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 10 | 2027-06-01 | 2026-11-02 |
| Lentiviral FVIII Gene Therapy YUVA-GT-F801 - Hemophilia A | Phase 1 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 10 | 2027-06-01 | 2026-10-30 |
| Prospective Clinical Investigation to Evaluate the Safety and Effectiveness of Juläine™ in Improving Gluteal Skin Laxity in Adults. Poly-L-Lactic Acid (Juläine™) - Skin Quality, Skin Laxity | Not applicable | Not yet recruiting | Nordberg Medical AB | 100 | 2027-06-01 | 2026-11-16 |
| Direct Lentiviral Injection Gene Therapy for MLD Intrathecal and intravenous LV gene therapy - Metachromatic Leukodystrophy (MLD) | Not applicable | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 10 | 2027-05-31 | 2026-11-02 |
Showing 20 of 17146. Sign in to see all of them.
Cystic Fibrosis (1585) · Dermatitis, Atopic (1526) · Anemia, Sickle Cell (1124) · Hemophilia A (791) · Muscular Dystrophy, Duchenne (481) · Down Syndrome (434) · Eczema (332) · Gout (309) · Huntington Disease (292) · Retinitis Pigmentosa (271) · beta-Thalassemia (264) · Hemophilia B (262) · Rare Diseases (248) · Cardiomyopathy, Dilated (244)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (17126) · Nervous System Diseases (5535) · Nutritional and Metabolic Diseases (4681) · Metabolic Diseases (4363) · Skin and Connective Tissue Diseases (3450) · Hemic and Lymphatic Diseases (3417) · Metabolism, Inborn Errors (3291) · Hematologic Diseases (3068) · Pathological Conditions, Signs and Symptoms (2892) · Immune System Diseases (2883) · Skin Diseases (2847) · Central Nervous System Diseases (2781) · Congenital Abnormalities (2641) · Brain Diseases (2557)
Blood Specimen Collection (191) · Factor VIII (136) · ivacaftor (109) · Cyclophosphamide (107) · Surveys and Questionnaires (107) · Exercise (96) · Sirolimus (96) · Hydroxyurea (89) · Sodium Chloride (89) · dupilumab (89) · Busulfan (76) · fludarabine (73) · fludarabine phosphate (64) · Saline Solution (63) · Alemtuzumab (62)
Assistance Publique - Hôpitaux de Paris (285) · Pfizer (199) · Novartis Pharmaceuticals (183) · National Institute of Allergy and Infectious Diseases (NIAID) (146) · National Cancer Institute (NCI) (144) · Vertex Pharmaceuticals Incorporated (138) · National Heart, Lung, and Blood Institute (NHLBI) (121) · Hospices Civils de Lyon (117) · Novo Nordisk A/S (114) · Shire (102) · Assiut University (101) · BioMarin Pharmaceutical (100) · Children's Hospital Medical Center, Cincinnati (99) · Massachusetts General Hospital (98) · Sanofi (91)
United States (7934) · France (2248) · United Kingdom (1888) · Germany (1610) · Canada (1606) · Italy (1448) · Spain (1265) · China (971) · Australia (903) · Netherlands (876) · Belgium (702) · Poland (630) · Turkey (Türkiye) (622) · Japan (528) · Israel (517)
PMID 39356039, PMID 37983082, PMID 33331662, PMID 36326435, PMID 31401903, PMID 37975597, PMID 36240296, PMID 39588375, PMID 31215818, PMID 33826132, PMID 40750723, PMID 41385299, PMID 30194931, PMID 33735508, PMID 33825230, PMID 33874971, PMID 37250503, PMID 37254256, PMID 37319354, PMID 39151033, PMID 42162528, PMID 27657681, PMID 32573764, PMID 32671834, PMID 34406619, PMID 36255569, PMID 36463457, PMID 36723913, PMID 37460385, PMID 38775255, PMID 38896380, PMID 40739200, PMID 40993471, PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 19775921, PMID 20236866, PMID 24144944, PMID 25075835, PMID 26196195, PMID 33165005, PMID 34256305, PMID 35061234, PMID 36408587, PMID 36449262, PMID 38489195, PMID 38649657, PMID 39104653
2023 (129), 2018 (116), 2017 (100), 2015 (91), 2016 (86), 2019 (80), 2025 (69), 2014 (68), 2009 (51), 2008 (41), U10CA180886 (28), U54NS065768 (19), 2005 (15), U10CA098543 (15), 2004 (10)